Trials / Completed
CompletedNCT04132050
A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
A Phase III Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy, safety and pharmacokinetics of R788 compared with placebo, and to investigate the safety and efficacy of long term dosing of R788 in patients with chronic idiopathic thrombocytopenic purpura.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | R788 | Oral administration |
| DRUG | Placebo | Oral administration |
Timeline
- Start date
- 2019-12-24
- Primary completion
- 2021-12-21
- Completion
- 2023-09-25
- First posted
- 2019-10-18
- Last updated
- 2025-08-11
- Results posted
- 2025-08-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04132050. Inclusion in this directory is not an endorsement.